Clinical evaluation of 5-ALA/SFC for cisplatin induced renal injury
Not Applicable
- Conditions
- nresectable gastric cancer
- Registration Number
- JPRN-UMIN000024642
- Lead Sponsor
- kawasaki medical school
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Contraindication cases of S-1 or cisplatin administration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety of 5-ALA/SFC as the prevention of renal failure supplement
- Secondary Outcome Measures
Name Time Method Renal failure depression effect